Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-001669-33Phase 4Completed
Phase 4 trial of allopurinol in subcortical infarction (SSI), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Change in MCA velocity induced by acetazolamide infusion. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-001669-33.